Pages that link to "Q28389823"

The following pages link to Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology (Q28389823):

Displayed 42 items.

• Immunotherapy for tuberculosis: future prospects (Q26741261) ‎ (← links)
• Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses (Q26823503) ‎ (← links)
• Novel adjunctive therapies for the treatment of tuberculosis (Q26829957) ‎ (← links)
• A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis (Q27004482) ‎ (← links)
• Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge (Q28088557) ‎ (← links)
• Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model (Q28480511) ‎ (← links)
• Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas (Q28480761) ‎ (← links)
• A Subset of Protective γ9δ2 T Cells Is Activated by Novel Mycobacterial Glycolipid Components (Q28829233) ‎ (← links)
• New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics (Q30371980) ‎ (← links)
• Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis (Q34113978) ‎ (← links)
• Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. (Q34480272) ‎ (← links)
• The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells (Q35125060) ‎ (← links)
• Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives (Q35743972) ‎ (← links)
• Spontaneous latency in a rabbit model of pulmonary tuberculosis. (Q36355577) ‎ (← links)
• Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model (Q36645097) ‎ (← links)
• Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis (Q36688480) ‎ (← links)
• Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment (Q36974934) ‎ (← links)
• Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis (Q37014319) ‎ (← links)
• Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology (Q37021677) ‎ (← links)
• Macrophages in tuberculosis: friend or foe. (Q37147624) ‎ (← links)
• Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice (Q37420861) ‎ (← links)
• Host-directed therapeutics for tuberculosis: can we harness the host? (Q38168037) ‎ (← links)
• Chemokines in tuberculosis: the good, the bad and the ugly (Q38274693) ‎ (← links)
• Host-Directed Therapies for Tuberculosis. (Q38489473) ‎ (← links)
• Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis. (Q38746059) ‎ (← links)
• Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers (Q38795742) ‎ (← links)
• Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing (Q40568831) ‎ (← links)
• Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response (Q42163682) ‎ (← links)
• Host-Directed Therapeutic Strategies for Tuberculosis (Q45006012) ‎ (← links)
• Lentinula edodes β-glucan enriched diet induces pro- and anti-inflammatory macrophages in rabbit. (Q47152127) ‎ (← links)
• Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials (Q48171420) ‎ (← links)
• Harnessing the mTOR Pathway for Tuberculosis Treatment (Q49417693) ‎ (← links)
• Tuberculosis and lung damage: from epidemiology to pathophysiology. (Q54264691) ‎ (← links)
• The wide utility of rabbits as models of human diseases. (Q55250836) ‎ (← links)
• The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy (Q58693717) ‎ (← links)
• Matrix Metalloproteinases in Pulmonary and Central Nervous System Tuberculosis—A Review (Q62734088) ‎ (← links)
• Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model (Q89497398) ‎ (← links)
• Inoculum size and traits of the infecting clinical strain define the protection level against Mycobacterium tuberculosis infection in a rabbit model (Q90043675) ‎ (← links)
• Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome (Q90268603) ‎ (← links)
• Therapeutic host-directed strategies to improve outcome in tuberculosis (Q91474358) ‎ (← links)
• Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis (Q92744801) ‎ (← links)
• A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE) (Q92842024) ‎ (← links)